Dr. Flowers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2000 - 2003- University of WashingtonResidency, Internal Medicine, 1997 - 2000
Stanford University School of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2020 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2022 - 2025
GA State Medical License 2003 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas Start of enrollment: 2023 Feb 23
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- American Society of Hematology: building a comprehensive minority recruitment and retention professional program.Margo R Rollins, Rahma M Warsame, Melody Smith, Arturo Molina, Rayne H Rouce
Blood Advances. 2024-12-24 - Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium.Jonathan R Day, Melissa C Larson, Urshila Durani, Jean L Koff, Yucai Wang
Blood Advances. 2024-11-27 - Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.Brooj Abro, Matthew J Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman
Blood. 2024-11-07
Press Mentions
MD Anderson Cancer Center and Myriad Genetics Sign Strategic AllianceJanuary 10th, 2025- MD Anderson and Myriad Genetics Partner on MRD Assay DevelopmentJanuary 8th, 2025
- MD Anderson and Myriad Genetics Join Forces to Assess Clinical Utility of Myriad’s Molecular Residual Disease AssayJanuary 7th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
